Indication
Postmenopausal urethral atrophy
Postmenopausal urethral atrophy is a lower urinary tract manifestation of genitourinary syndrome of menopause (GSM), caused by declining circulating estrogen levels following menopause. Read more about Postmenopausal urethral atrophy
2 drugs 2 manufacturers
Drugs that treat it
Common Postmenopausal urethral atrophy therapies.
ESTRING (estradiol)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPostmenopausal urethral atrophy is a lower urinary tract manifestation of genitourinary syndrome of menopause (GSM), caused by declining circulating estrogen levels following menopause.
Due to shared embryologic origins with the vaginal epithelium, the female urethra is rich in estrogen receptors; estrogen deficiency leads to cellular thinning of the mucosal lining, loss of vascularity, reduced collagen elasticity, and impairment of the urethral mucosal seal.
Clinically, affected postmenopausal women present with irritative urinary symptoms, including dysuria, frequency, urgency, urge or stress urinary incontinence, and an increased susceptibility to recurrent urinary tract infections.
- nih.gov
Postmenopausal urethral atrophy is a lower urinary tract manifestation of genitourinary syndrome of menopause (GSM), caused by declining circulating estrogen levels following menopause Clinically, affected postmenopausal women present with irritative urinary symptoms, including dysuria, frequency, urgency, urge or stress urinary incontinence, and an increased susceptibility to recurrent urinary tract infections
- rigicon.com
Postmenopausal urethral atrophy is a lower urinary tract manifestation of genitourinary syndrome of menopause (GSM), caused by declining circulating estrogen levels following menopause Due to shared embryologic origins with the vaginal epithelium, the female urethra is rich in estrogen receptors; estrogen deficiency leads to cellular thinning of the mucosal lining, loss of vascularity, reduced collagen elasticity, and impairment of the urethral mucosal seal Clinically, affected postmenopausal wo...
- thischangedmypractice.com
Due to shared embryologic origins with the vaginal epithelium, the female urethra is rich in estrogen receptors; estrogen deficiency leads to cellular thinning of the mucosal lining, loss of vascularity, reduced collagen elasticity, and impairment of the urethral mucosal seal
Personalize your experience
Follow Postmenopausal urethral atrophy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.